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Abstract A general method for calculating doses absorbed
from isotopes released in nuclear accidents is presented. As
an example, this method was used to calculate doses for
inhabitants of Southern Poland due to inhalation of 131I
released due to the Fukushima nuclear plant accident. 131I
activity measurements in the air of that region provided the
basis for the study. The proposed model is based on a
complex biokinetic model for iodine merging the Leggett
model developed in 2010 with the human respiratory tract
and gastrointestinal tract models recommended by the
International Commission on Radiological Protection
(ICRP). This model is described here, and it is demon-
strated that resulting dose estimates are consistent with
those obtained using the ICRP methodology. Using the
developed model, total doses were calculated for six age
groups of both genders, for gaseous and aerosol fractions
alike. The committed effective dose, H50, for an adult man
reached 16 nSv, which is lower than 0.001% of the back-
ground dose. The dose for the thyroid of an adult reached
0.33 lSv, which corresponds to circa 0.0007% of the dose
to the population of Southern Poland after the Chernobyl
nuclear plant accident.
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Introduction
On 11 March 2011, a 9.0 magnitude earthquake took place
off the Pacific coast of To¯hoku, Japan. Subsequent 13-m-
high tsunami waves damaged the cooling system (Tanaka
2012; Lipscy et al. 2013) at the Fukushima Daiichi Nuclear
Power Plant. As a consequence, a radioactive emission
occurred on the 12th of March containing mainly 131I, 133I,
134Cs, 137Cs, and other volatile species, which were
transported in the atmosphere towards the north-western
direction (Tanaka 2012). The accident was classified in the
International Nuclear Event Scale as a level 7 accident.
Previously, only the Chernobyl accident was rated at this
level. During this accident, 1.8 9 1018 Bq of 131I were
released into the environment (UNSCEAR 2000), whereas
during the Fukushima accident 0.12 9 1018 Bq of 131I were
released (USCEAR 2014).
The first traces from the Fukushima radioactive plume in
Europe were detected in Reykjavik, Iceland, on the 20th of
March (Bossew et al. 2012). On the morning of the 24th of
March, the Laboratory of Radioactivity Analyses in Kra-
kow, Poland, initiated an emergency mode for observations
of radionuclides in the atmosphere; both aerosols and a
gaseous fraction of 131I were considered (Mietelski et al.
2014).
131I is a beta-emitting radioisotope with a physical half-
life of 8.021 days. The mean energy of electrons released
during 131I nuclear decay is 606 keV. 131I is a nuclear
fission product and as such it is commonly present in
radioactive releases due to nuclear power plant failures.
Furthermore, it is believed to contribute significantly to
health hazards related to radioactive fallout. Being an
iodine radioisotope, 131I is easily and preferentially con-
centrated in the human thyroid; note that the thyroid
accumulates 30% of the total intake of iodine (Johansson
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et al. 2003) which is necessary for the proper functioning of
the thyroid.
The International Commission on Radiological Protec-
tion (ICRP) developed a general methodology to calculate
dose conversion factors and dose coefficients. This
methodology was applied in the present study to estimate
doses received by an average Polish citizen due to
inhalation of 131I from the Fukushima fallout. More
specifically, to quantify the incorporation of aerosol and
gaseous fractions of radioiodine in the human organism,
the age-dependent systemic biokinetic model proposed by
Leggett (2010) was combined with the ICRP human res-
piratory tract model (HRTM) (ICRP 1994) and the ICRP
gastrointestinal tract model (GITM) (ICRP 1979).
Materials and method
A general method of dose calculation is presented in this
section. First, 131I concentration in the air was measured.
Second, gaseous and aerosol 131I fractions deposited in
various lung regions were estimated. Next, a complete
biokinetic model for modelling the translocation of the
deposited radionuclide within a human body following
inhalation was constructed. Finally, ICRP recommenda-
tions were applied to evaluate equivalent and effective
doses.
131I measurements
Iodine from the air was collected at the Institute of Nuclear
Physics in Krakow, Poland, by a combined aerosol sampler
MASS-500/gas sampler, operated at a flow rate of
250 m3 h-1 (Mietelski et al. 2014; Masson et al. 2011).
The sorbent type for the aerosol fraction was a Petryanov
filter FPP-15-1.5 (poly(vinyl chloride)) which has good
aerosol-collecting properties: The aerosol collection effi-
ciency of the Petryanov filter for aerosols with diameters
0.3 lm and for a linear velocity of the air passing through
the filter of about 0.36 m s-1 reached 96.7% (Lipin´ski
et al. 2013). For collection of the gas fraction, a sorbent of
granular activated carbon impregnated with KI (IBJ-6,
mesh size 2 mm, produced by Gryskand, Hajno´wka,
Poland) was used. The average efficiency of gaseous iodine
adsorption reached (67 ± 11)% (Table 1). The use of
activated carbon impregnated with KI allowed collection of
both organic and inorganic iodine (Wilhelm 1982; Wang-
chang et al. 1993).
Between the 21st of March and 12th of April, the sorbents
were changed every day. The filters and the granulated carbon
from the gas cassettes were analysed by means of a low-
background gamma spectrometer with HPGe detectors. Prior
to measurements, the filters were compressed into pellets of
5 cm diameter and about 4 mm height. The carbon from each
cassette was transferred into 0.5-L plastic Marinelli beakers
andmeasured. Isotopes such as 131I, 132I, 129mTe, 132Te, 134Cs,
136Cs, and 137Cs were detected in the filters. The maximum
activity for aerosols was equal to (5.73 ± 0.35),
(0.461 ± 0.041) and (0.436 ± 0.038) mBq m-3 for 131I,
134Cs, and 137Cs, respectively, as observed on 29March 2011.
The detailed results are presented in Table 1 (Masson et al.
2011, 2013; Mietelski et al. 2014).
Deposition in the human respiratory tract
In the present study, the HRTM published in ICRP (1994)
was used. In this approach, the human respiratory tract is
divided into four anatomical regions, namely the
extrathoracic region ET (consists of two parts: ET1 com-
prising interior nose and ET2 comprising posterior nasal
passages, larynx, pharynx, and mouth), the bronchial
region BB, the bronchiolar region bb, and the alveolar–
interstitial region AI. The deposition of 131I aerosol frac-
tions was calculated for five activity median aerodynamic
diameters (AMADs) of the attached aerosols that were
observed in Southern Poland after the Fukushima accident,
i.e. 0.35, 0.36, 0.38, 0.47, and 0.53 lm (Masson et al.
2013). The deposition was calculated by a logarithmic
interpolation of the deposition fraction values published by
the ICRP in the HRTM using a six-term exponential
function. Exemplary depositions for an adult male and a
0.35 lm aerosol AMAD are presented in Table 2.
In the gas fraction, iodine in elemental and organic form
is absorbed in the respiratory tract in various proportions.
However, when it is not possible to distinguish them (as
was the case in the present study), the ICRP recommends
adoption of the deposition rate for elemental iodine;
accordingly, 100% deposition in the respiratory tract for
elemental iodine was assumed in the present study with the
respective distribution of 10% ET1, 40% ET2, and 50%
BB (ICRP 1995). This simplification resulted in an over-
estimation of the calculated doses. In general, the fractional
deposition in the respiratory tract regions was estimated for
six age groups, both genders and four exercise levels,
notably sitting, sleeping, light exercise, and heavy exercise.
The typical time-budget distribution of different activities
for 3-month infants was assumed as 71–29% for sleeping
and light exercises, respectively, while the typical time
budget for an adult male was assumed to be 33, 25, 41, and
1% for sleeping, sitting, light exercise, and heavy exercise,
respectively. The average breathing rate for an adult man is
22.2 m3 day-1, while the breathing rates for the other age
groups are 2.86 m3 day-1 for 3-month-old infants,
5.16 m3 day-1 for 1-year-olds, 8.72 m3 day-1 for 5-year-
olds, 15.3 m3 day-1 for 10-year-olds, 20.1 m3 day-1 for
15-year-old males, 18 m3 day-1 for 15-year-old females,
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and 17.8 m3 day-1 for adult females. These breathing rates
and other detailed ventilation parameters used in the model
were taken from ICRP (2002) and are presented in Table 3.
Biokinetic models
To describe the behaviour of the inhaled 131I in the human
body and iodine accumulation in organs and tissues, the
systemic biokinetic compartment model by Leggett (2010),
the HRTM, and GITM were combined together into a one-
compartment model. Such a solution has already been
successfully applied for calculation of doses due to
inhalation of indoor short-lived radon (both 222Rn and
220Rn) progenies for members of the public (Lie et al.
2008; Brudecki et al. 2014). The model is based on three
subsystems for extrathyroidal inorganic iodine, thyroidal
iodine, and extrathyroidal organic iodine. The model flow
chart is presented in Fig. 1.
In the model, transfer of organic and hormonal iodine
between compartments is characterized by transfer coeffi-
cients defined as the transferred fraction of the source
compartment content per unit time. The factors used here
Table 1 Results of gamma spectrometric measurements of ground air activity concentration in Krako´w, Poland, for one-day sampling cycle
(Masson et al. 2011, 2013; Mietelski et al. 2014)












2011.03.21 2011.03.24 17,957 105 ± 5 0.38 135 ± 42 69
2011.03.24 2011.03.25 5975 84 ± 7 286 ± 103 41
2011.03.25 2011.03.26 6386 \12 \48 46
2011.03.26 2011.03.27 5256 840 ± 37 604 ± 170 75
2011.03.27 2011.03.28 7468 1570 ± 60 2040 ± 860 61
2011.03.28 2011.03.29 5385 3600 ± 200 0.36 5200 ± 1200 69
2011.03.29 2011.03.30 5763 5730 ± 350 5220 ± 340 68
2011.03.30 2011.03.31 7264 2910 ± 120 3360 ± 260 78
2011.03.31 2011.04.01 6177 908 ± 42 0.35 1120 ± 110 73
2011.04.01 2011.04.02 6396 668 ± 33 227 ± 20 69
2011.04.02 2011.04.03 6628 718 ± 35 145 ± 15 74
2011.04.03 2011.04.04 6230 2151 ± 90 406 ± 27 69
2011.04.04 2011.04.05 8201 413 ± 18 0.47 95 ± 15 81
2011.04.05 2011.04.06 4261 494 ± 27 224 ± 44 76
2011.04.06 2011.04.07 6689 650 ± 27 250 ± 27 71
2011.04.07 2011.04.08 6554 438 ± 48 316 ± 46 61
2011.04.08 2011.04.09 6067 308 ± 20 90 ± 12 70
2011.04.09 2011.04.10 6788 182 ± 16 0.53 191 ± 20 72
2011.04.10 2011.04.11 6625 239 ± 15 358 ± 34 45
2011.04.11 2011.04.13 12,882 157 ± 13 59 ± 15 60
Table 2 Depositions in the
ICRP human respiratory tract
model (HRTM) for an adult
male and a 0.35 lm AMAD
aerosol diameter
Region Exercise levels
Sleeping Sitting Light exercise Heavy exercise
ET1 3.41 9 10-2 3.02 9 10-2 7.23 9 10-2 3.36 9 10-2
ET2 3.12 9 10-2 3.91 9 10-2 8.21 9 10-2 4.69 9 10-2
BB fast and seq 4.56 9 10-3 4.03 9 10-3 2.69 9 10-3 5.78 9 10-3
BB slow 4.04 9 10-3 3.77 9 10-3 3.11 9 10-3 6.84 9 10-3
bb fast and seq 1.65 9 10-2 2.45 9 10-2 1.24 9 10-2 1.02 9 10-2
bb slow 2.77 9 10-2 2.52 9 10-2 1.14 9 10-2 1.08 9 10-2
AI 1.33 9 10-1 1.53 9 10-1 1.29 9 10-1 1.42 9 10-1
ET1, extrathoracic region; ET2, posterior nasal passages; BB, bronchial; bb, bronchiolar; AI, alveolar–
interstitial
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are presented in Table 4. It is presupposed that inhaled
iodine is quickly and entirely absorbed into the blood,
where the iodine in red blood cells (RBCs) and plasma is
assumed to be the same; therefore, the blood iodine is
treated as a mixed pool. Another assumption is that iodine
is excreted solely through urine and faeces (more than 90%
of iodine removal is caused by renal clearance). Sweat
secretion seems to be a negligible contribution to iodine
loss. It is worth pointing out that only liver and kidney
compartments were divided into two regions representing
organic and inorganic iodide. The reasons for such speci-
fication are that kidneys are a greater extrathyroidal
repository of organic and inorganic iodine, whereas liver
stores much more hormonal iodine than any other
extrathyroidal organ.
The model proposed by Leggett in 2010 is a biokinetic
model for iodine for adults. Note that differences in the
biokinetics of iodine between age groups are caused pri-
marily by differences in iodine retention in the thyroid. The
biological half-life of iodine for the thyroid is 11.2, 15, 23,
58, 67, and 90 days, for infants, 1-, 5-, 10-, and 15-year-old
children and adults, respectively (ICRP 1993; Leggett 2010).
In Leggett’s model, the time of iodine retention in the thy-
roid corresponds to the ‘‘Thyroid 2 to 2 Blood’’ parameter.
Based on the values for biological half-life of iodine given
above, this factor corresponds to 0.0619, 0.0462, 0.0301,
0.0119, 0.0103, and 0.0077 day-1 for infants, 1-, 5-, 10-,
and 15-year-old children and adults, respectively.
The biokinetic behaviour of the inhaled iodine in the
respiratory tract and other organs can be described by a
system of first-order linear differential equations. The
iodine activity in tissue and organs at any time after intake
can be calculated numerically by solving these equations.
The time-integrated iodine activity ~A in the thyroid and in
other organs was calculated hereby integrating the activity
in the organ up to the age of 70 years for children and over
the 50-year commitment period following the intake for
adults. The system of first-order differential equations was
solved using the commercially available software SAAM II
(Epsilon Group, VA, USA) (Barrett et al. 1998).
Table 3 Daily time budget and ventilation parameters at each exercise level for members of the public (ICRP 2002)
Age Time budget (h) Breathing rate (m3 h-1)
Sleeping Sitting Light exercise Heavy exercise Sleeping Sitting Light exercise Heavy exercise Average
3 months 17 – 7 – 0.09 – 0.19 – 0.12
1 year 14 3.33 6.67 – 0.15 0.22 0.35 – 0.22
5 years 12 4 8 – 0.24 0.32 0.57 – 0.36
10 year 10 4.67 9.33 – 0.31 0.38 1.1 – 0.64
15 years male 10 5.5 7.5 1 0.42 0.48 1.4 2.9 0.84
15 years female 10 5.5 7.5 1 0.35 0.40 1.3 2.6 0.75
Adult male 8 6 9.75 0.25 0.45 0.54 1.5 3.0 0.93
Adult female 8 6 9.75 0.25 0.32 0.39 1.2 2.7 0.74
Fig. 1 General biokinetic model used in the present study. The model combines ICRP human respiratory track model and gastrointestinal tract
model and Leggett systemic model (Leggett 2010; ICRP 1979, 1994)
12 Radiat Environ Biophys (2017) 56:9–17
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Equivalent dose and effective dose
The general methodology for dose calculation developed
by the ICRP was also applied in the present study.
Equivalent thyroid doses were calculated based on the
time-integrated activity ~A and radiation-weighted SW fac-
tors. In general, the equivalent dose H(rT, TD) in any target
organ rT at age T integrated over the dose integration
period TD is given by Eq. (1) (Bolch et al. 2009)





A rS; tð ÞSW rT  rS; tð Þdt; ð1Þ
where A(rS, t) is the time-dependent activity in the source
region rS at time t; SW(rT / rS, t) is the radiation-weighted
S factor, which depends on the radiation-weighting factor
wR and energy ER of radiation R. S is calculated as given in
Eq. (2)
SW rT  rS; tð Þ ¼
X
R
wRS rT  rS;ER; tð Þ: ð2Þ
For a given age group, SW(rT / rS, t) is constant over the
time interval TD






A rS; tð Þdt: ð3Þ
Consistently, the equivalent dose in a specific age group is
(Eq. 4)







Dð ÞSW rT  rSð Þ: ð4Þ
Finally, the equivalent dose is calculated according to
Eq. (5) by summing all the equivalent doses of each time
interval as
H rT ; TDð Þ ¼
X
all ages
H rT ; T
age
Dð Þ: ð5Þ
Subsequently, the effective dose for a certain gender, E,
may be calculated by Eq. (6) by summing equivalent






Following the new ICRP recommendations (ICRP 2007),
the effective dose, E, for adults is calculated from the
average of adult female (HFemaleT ) and adult male (H
Male
T )









In the present investigation, the effective doses for adults and
15-year-olds are estimated based on the adequate female and
male equivalent doses and ICRP 103 (2007) recommenda-
tions. For the other age groups, i.e. infants, 1-, 5-, and 10-year-
olds, the effective doses are calculated without taking into
consideration gender differences, according to ICRP (1991).
In practice, the SW value was calculated using the
SEECAL program (Oak Ridge National Laboratory, Oak
Ridge, TN, USA). The time-dependent activity, A(rS, t),
was obtained by modelling for separate anatomical regions
(Fig. 1) and the wT values used for calculations were taken
from ICRP 60 (1991). Tissue-weighting factors, wT, were
taken from ICRP 60 (1991) instead of ICRP 103 (2007), to
allow validation of the model and comparison of the results
with ICRP dose coefficients (ICRP 1995).
Table 4 Parameter values of the Leggett 131I systemic model (Leg-
gett 2010)
Pathway Transfer coefficient (day-1)
Blood 1 to thyroid 1 7.26
Blood 1 to urinary bladder contents 11.84
Blood 1 to salivary glands 5.16
Blood 1 to stomach wall 8.60
Blood 1 to other 1 600
Blood 1 to kidneys 1 25
Blood 1 to liver 1 15
Salivary glands to stomach contents 50
Stomach wall to stomach contents 50
Thyroid 1 to thyroid 2 95
Thyroid 1 to blood 1 36
Thyroid 2 to blood 2 0.0077
Thyroid 2 to blood 1 0
Other 1 to blood 1 330
Other 1 to other 2 35
Other 2 to other 1 56
Kidney 1 to blood 1 100
Liver 1 to blood 1 100
Blood 2 to other 3 15
Other 3 to blood 2 21
Other 3 to other 4 1.2
Other 4 to other 3 0.62
Other 4 to blood 1 0.14
Blood 2 to kidneys 2 3.6
Kidneys 2 to blood 2 21
Kidneys 2 to blood 1 0.14
Blood 2 to liver 2 21
Liver 2 to blood 2 21
Liver 2 to blood 1 0.14
Stomach contents to SI contents 20.57
SI contents to blood 1 594
Urinary bladder contents to urine 12
Radiat Environ Biophys (2017) 56:9–17 13
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Validation of the method
To validate the methods applied, the estimated doses were
compared with those obtained using ICRP dose coefficients
(ICRP 1995) for the gaseous fraction of 131I. Results are
presented in Table 5. The biggest differences are observed
for infants (36%) and 1-year-old children (16%). In the
other age groups, differences are around 10%. Such dis-
crepancies occurred owing to the fact that Leggett’s model
is more accurate than the current ICRP model proposed by
Riggs (1952).
Results and discussion
In the present study, doses to South Poland residents due to
inhalation of 131I were calculated, based on the 131I mea-
sured in air in South Poland after the nuclear power plant
accident in Fukushima. The resulting effective doses and
equivalent doses for the thyroid obtained for six age
groups, namely 3-month infants, 1-, 5-, 10-, 15-year-old,
and adults, as well as both genders for adults and 15-year-
old teenagers, are shown in Tables 6 and 7.
With regard to the aerosol fraction, as expected the
highest equivalent dose was achieved for the thyroid. The
estimated doses for this organ were equal to 1.0 9 10-7,
1.9 9 10-7, 1.5 9 10-7, 1.0 9 10-7, 7.7 9 10-8,
6.9 9 10-8, 5.7 9 10-8, and 4.6 9 10-8 Sv for infants, 1-,
5-, 10-year-old children, 15-year-old males, 15-year-old
females, male and female adults, respectively. The
equivalent doses received by other body parts usually did
not exceed hundreds of pSv. The largest effective dose
(9.6 nSv) was calculated for a 1-year-old child, while for
older ages, lower values were calculated (Fig. 2).
As far as the gaseous fraction of 131I is concerned, the
thyroid was the organ with the highest equivalent doses,
similarly to the case of the aerosol fraction. The thyroid
equivalent doses were equal to 3.8 9 10-7, 5.5 9 10-7,
5.1 9 10-7, 4.5 9 10-7, 3.9 9 10-7, 3.4 9 10-7,
2.7 9 10-7, and 2.1 9 10-7 Sv for infants, 1-, 5-, 10-year-
old children, 15-year-old males, 15-year-old females, male
and female adults, respectively. Corresponding effective
doses ranged from 28 nSv for a 1-year-old child to 11 nSv
for an adult female (Fig. 3).
It should be noted that the doses calculated due to the
gaseous fraction are overestimated. As already mentioned
above, elemental and organic iodine in the gas fraction are
absorbed in the respiratory tract in various proportions:
100% of elemental iodine is absorbed while only 70% of
organic iodine is absorbed. For an adult male, the differ-
ence between the effective dose due to inhalation of ele-
mental iodine and organic iodine is 25% (ICRP 1995).
Because we were not able to distinguish between elemental
and organic iodine in the gas fraction, it was assumed that
all was elemental iodine and a 100% absorption was used,
consistent with the recommendations of the ICRP. This led
to a conservative dose assessment. Considering that
organic iodine constitutes up to 86% of the total gaseous
fraction (Noguchi and Murata 1988), doses estimated in the
Table 5 Effective dose in Sv for the 131I gas fraction
3 month 1 year 5 years 10 years 15 years # 15 years $ Adult # Adult $
Eff dose (present method) 1.9 9 10-8 2.8 9 10-8 2.6 9 10-8 2.3 9 10-8 1.9 9 10-8 1.7 9 10-8 1.4 9 10-8 1.1 9 10-8
Eff dose (ICRP 71, dose
coefficients)
1.4 9 10-8 2.4 9 10-8 2.3 9 10-8 2.1 9 10-8 1.8 9 10-8 1.6 9 10-8 1.3 9 10-8 1.0 9 10-8
Difference 36% 16% 13% 10% 6% 6% 8% 10%
Table 6 Inhalation dose in Sv for the 131I aerosol fraction
3 month 1 year 5 years 10 years 15 years # 15 years $ Adult # Adult $
Thyroid 1.0 9 10-7 1.9 9 10-7 1.5 9 10-7 1.0 9 10-7 7.7 9 10-8 6.9 9 10-8 5.7 9 10-8 4.6 9 10-8
Effective dose 5.3 9 10-9 9.6 9 10-9 7.3 9 10-9 5.2 9 10-9 3.9 9 10-9 3.5 9 10-9 2.8 9 10-9 2.3 9 10-9
Table 7 Inhalation dose in Sv for the 131I gas fraction
3 month 1 year 5 years 10 years 15 years # 15 years $ Adult # Adult $
Thyroid 3.8 9 10-7 5.5 9 10-7 5.1 9 10-7 4.5 9 10-7 3.9 9 10-7 3.4 9 10-7 2.7 9 10-7 2.1 9 10-7
Effective dose 1.9 9 10-8 2.8 9 10-8 2.6 9 10-8 2.3 9 10-8 1.9 9 10-8 1.7 9 10-8 1.4 9 10-8 1.1 9 10-8
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present study were probably overestimated by up to about
23%.
In general, the effective doses from iodine in the gaseous
fraction are higher than those from iodine attached to aero-
sols: The gas-to-aerosol effective dose ratios are equal to 3.6,
2.9, 3.5, 4.4, 5.0, 4.8, and 4.7 for infant, 1-, 5-, 10-year-old
children, 15-year-old boys and girls, adult men and women,
respectively. Such differences in dose between the gaseous
and aerosol fractions are caused by differences in deposition
in the respiratory system.Accumulation of volatile (gaseous)
iodine is between 70% and 100%, while the maximum
deposition of particulate iodine (iodine attached to aerosols)
observed in Southern Poland is on the 43% level for 0.53-
lm-diameter particles for a 1-year-old child.
The sum of the thyroid doses induced by the iodine
attached to aerosols or present in the gaseous fraction (and
assuming 100% absorption) is equal to 0.48, 0.74, 0.66,
0.55, 0.46, 0.41, 0.33, and 0.26 lSv for infants, 1-, 5-,
10-year-old children, 15-year-old boys and girls, adult men
and women, respectively. Compared with inhalation doses
of 131I by Polish residents after the Chernobyl nuclear
accident, when equivalent doses for the thyroid reached
178, 120, and 45 mSv for 5-year-old children, 10-year-old
children, and adults, respectively (Pietrzak-Flis et al.
2003), the values due to the Fukushima accident are
practically negligible. Similarly, the effective doses esti-
mated here for Southern Poland are significantly lower than
those estimated for the inhabitants of Fukushima and
Japan: Depending on the residence place, thyroid doses for
Japanese people were estimated as (0.1 7 4.3),
(0.1 7 5.9), and (0.2 7 7.5) mSv for adults, 10-year-old
children, and 1-year-old children, respectively (UNSCEAR
2014). The doses found in the present study are consistent
with those estimated by WHO (2012), who estimated for
areas outside Japan effective doses of less than 0.01 mSv.
In the present paper, dose evaluation was performed for
adults and 15-year-old teenagers for male and female
separately, although ICRP recommends (ICRP 103) to
calculate doses for adults as the average of the two genders
(see Eq. 7). Differences found between these two approa-
ches are presented in Table 8; the biggest discrepancy
reached 13%.
Fig. 2 Effective dose due to
aerosol fraction of 131I as a
function of age
Fig. 3 Effective dose due to
gas fraction of 131I as a function
of age
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Conclusions
In the present study, doses due to 131I originating from the
Fukushima Daiichi Nuclear Power Plant accident inhaled
by residents of Southern Poland were estimated. The doses
were calculated for both 131I in aerosol and 131I in gaseous
fractions. The dose values due to volatile iodine in the
gaseous fraction were found to be higher than those esti-
mated for particulate iodine (i.e. iodine attached to aero-
sols); the difference can be attributed to differences in the
deposition of the discussed fractions in the human respi-
ratory tract. The effective committed dose, H50, for a male
adult reached 16 nSv, which is less than 0.001% of the
local background dose. The thyroid dose for an adult
reached 0.33 lSv, which is less than 0.0007% of the dose
that had been estimated for residents of Southern Poland,
due to the Chernobyl accident. The doses to the inhabitants
of Southern Poland did by no means represent any health
hazard. Moreover, 131I air concentrations were comparable
in most European countries (especially Central and Eastern
parts of Europe). Therefore, the presented dose calculations
are representative not only for Poles but also for most
Europeans.
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